Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Laboratories | 1 | 2020 | 2858 | 0.34 | Why? |
| Immunoglobulins | 2 | 2019 | 811 | 0.25 | Why? |
| X Chromosome Inactivation | 1 | 2019 | 23 | 0.20 | Why? |
| Immunoglobulin Light Chains | 1 | 2019 | 62 | 0.19 | Why? |
| Chromosomes, Human, X | 1 | 2019 | 81 | 0.19 | Why? |
| Multiple Myeloma | 2 | 2019 | 1064 | 0.19 | Why? |
| Hematopoiesis | 1 | 2019 | 168 | 0.19 | Why? |
| Polysaccharides, Bacterial | 1 | 2018 | 59 | 0.18 | Why? |
| Private Sector | 1 | 2020 | 262 | 0.18 | Why? |
| Technology, Pharmaceutical | 1 | 2018 | 82 | 0.17 | Why? |
| Common Variable Immunodeficiency | 1 | 2019 | 195 | 0.16 | Why? |
| Pneumonia, Pneumococcal | 1 | 2018 | 251 | 0.14 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.13 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Pneumococcal Vaccines | 1 | 2018 | 571 | 0.12 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.09 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.09 | Why? |
| Immunologic Memory | 1 | 2019 | 3362 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.08 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.08 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.07 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Taq Polymerase | 1 | 2021 | 31 | 0.06 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.05 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2019 | 501 | 0.04 | Why? |
| B-Lymphocyte Subsets | 1 | 2019 | 372 | 0.04 | Why? |
| Receptors, Androgen | 1 | 2019 | 212 | 0.04 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.04 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.04 | Why? |
| Linear Models | 1 | 2021 | 1914 | 0.03 | Why? |
| Immunophenotyping | 1 | 2019 | 1290 | 0.03 | Why? |
| DNA Methylation | 1 | 2019 | 688 | 0.03 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2019 | 1444 | 0.03 | Why? |
| Cell Differentiation | 1 | 2019 | 1338 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.03 | Why? |
| Humans | 13 | 2021 | 930598 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2019 | 2742 | 0.02 | Why? |
| England | 1 | 2021 | 5116 | 0.02 | Why? |
| Cells, Cultured | 1 | 2019 | 5835 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Universities | 1 | 2021 | 4374 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2019 | 4849 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Female | 4 | 2021 | 380317 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Adult | 2 | 2021 | 244371 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Male | 2 | 2021 | 367725 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |
Richter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(89)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(104)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_